Author:
Zhang Mengyan,Qiao Longchong,Sun Peiwen,Jiang Haiqin,Shi Ying,Zhang Wenyue,Mei Youming,Yu Meiwen,Wang Hongsheng
Abstract
Abstract
Background
Despite many efforts to control leprosy worldwide, it is still a significant public health problem in low- and middle-income regions. It has been endemic in China for thousands of years, and southwest China has the highest leprosy burden in the country.
Methods
This observational study was conducted with all newly detected leprosy cases in southwest China from 2010 to 2020. Data were extracted from the Leprosy Management Information System (LEPMIS) database in China. The Joinpoint model was used to determine the time trends in the study area. Spatial autocorrelation statistics was performed to understand spatial distribution of leprosy cases. Spatial scan statistics was applied to identify significant clusters with high rate.
Results
A total of 4801 newly detected leprosy cases were reported in southwest China over 11 years. The temporal trends declined stably. The new case detection rate (NCDR) dropped from 4.38/1,000,000 population in 2010 to 1.25/1,000,000 population in 2020, with an average decrease of 12.24% (95% CI: −14.0 to − 10.5; P < 0.001). Results of global spatial autocorrelation showed that leprosy cases presented clustering distribution in the study area. Most likely clusters were identified during the study period and were frequently located at Yunnan or the border areas between Yunnan and Guizhou Provinces. Secondary clusters were always located in the western counties, the border areas between Yunnan and Sichuan Provinces.
Conclusions
Geographic regions characterized by clusters with high rates were considered as leprosy high-risk areas. The findings of this study could be used to design leprosy control measures and provide indications to strengthen the surveillance of high-risk areas. These areas should be prioritized in the allocation of resources.
Funder
The National Key R&D Program of China
National Natural Science Foundation of China
Jiangsu Provincial Medical Key Laboratory, Jiangsu Province Capability Improvement Project through Science, Technology and Education
The Nanjing Incubation Program for National Clinical Research Center
Chinese Academy of Medical Sciences Innovation Fund for Medical Science
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Deps P, Cruz A. Why we should stop using the word leprosy. Lancet Infect Dis. 2020;20:e75–8.
2. Cardona-Castro N, Escobar-Builes MV, Serrano-Coll H, Adams LB, Lahiri R. Mycobacterium lepromatosis as cause of Leprosy, Colombia. Emerg Infect Dis. 2022;28:1067–8.
3. WHO. Towards zero leprosy: Global Leprosy (Hansen’s disease) Strategy 2021–2030 2021. Available from: https://www.who.int/publications/i/item/9789290228509.
4. Bulstra CA, Blok DJ, Alam K, Butlin CR, Roy JC, Bowers B, et al. Geospatial epidemiology of leprosy in northwest Bangladesh: a 20-year retrospective observational study. Infect Dis Poverty. 2021;10:36.
5. Sarode G, Sarode S, Anand R, Patil S, Jafer M, Baeshen H, et al. Epidemiological aspects of leprosy. Dis Mon. 2020;66: 100899.